Sun, Sep 21, 2014, 7:23 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

doctorinnio 4 posts  |  Last Activity: Jul 15, 2014 3:54 PM Member since: Mar 6, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • doctorinnio doctorinnio Jul 15, 2014 3:54 PM Flag

    If you are the country with the biggest obesity problem where over 30% of population is obese, you need to act and act fast. And I believe that they have to approve Belviq. No other efficient choices! Sales tax on pop and soda won't matter because if you crave it you will buy it no matter what! So even thought approval is not garranted and it may drop like 30% if rejected, common sense tells me that Mexico government will approve it to show the UN they are taking steps to combat obesity and diabetes. And if approved I see close to 100% pop.

    My 2 cents

    Sentiment: Hold

  • OR a steady move up if sales ramp up!

    Sentiment: Hold

  • They must actually.

    Sentiment: Hold

  • doctorinnio by doctorinnio Jul 15, 2014 10:53 AM Flag

    United States Patent 8,778,950
    Jones , et al. July 15, 2014

    Cannabinoid receptor modulators

    The present invention relates to certain compounds of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor. The present invention further relates to certain compounds of Formula Ia and pharmaceutical compositions thereof that modulate the activities of both the CB1 receptor and the CB2 receptor. Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of: pain, for example bone and joint pain, muscle pain, dental pain, migraine and other headache pain, inflammatory pain, neuropathic pain, pain that occurs as an adverse effect of therapeutics and pain associated with osteoarthritis; hyperalgesia; allodynia; inflammatory hyperalgesia; neuropathic hyperalgesia; acute nociception; osteoporosis; multiple sclerosis-associated spasticity; autoimmune disorders; allergic reactions; CNS inflammation; atherosclerosis; undesired immune cell activity and inflammation; age-related macular degeneration; cough; leukemia; lymphoma; CNS tumors; prostate cancer; Alzheimer's disease; stroke-induced damage; dementia; amyotrophic lateral sclerosis, and Parkinson's disease.

    Sentiment: Hold

13.21+0.03(+0.23%)Sep 19 4:15 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.